These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1468531)

  • 21. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada.
    Blahna MT; Zalewski CA; Reuer J; Kahlmeter G; Foxman B; Marrs CF
    J Antimicrob Chemother; 2006 Apr; 57(4):666-72. PubMed ID: 16464890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE; Rensimer ER; DuPont HL
    N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution and transferability of plasmids in trimethoprim resistant urinary Escherichia coli.
    Kraft CA; Platt DJ; Timbury MC
    J Med Microbiol; 1983 Nov; 16(4):433-41. PubMed ID: 6358500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High level resistance to trimethoprim, cotrimoxazole and other antimicrobial agents among clinical isolates of Shigella species in Ontario, Canada--an update.
    Harnett N
    Epidemiol Infect; 1992 Dec; 109(3):463-72. PubMed ID: 1468530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999.
    Karlowsky JA; Jones ME; Thornsberry C; Critchley I; Kelly LJ; Sahm DF
    Int J Antimicrob Agents; 2001 Aug; 18(2):121-7. PubMed ID: 11516934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug-resistant urinary tract isolates of escherichia coli from Ribeirão Preto, São Paulo, Brazil.
    Santo E; Salvador MM; Marin JM
    Braz J Infect Dis; 2007 Dec; 11(6):575-8. PubMed ID: 18327470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Weshnoweski B; Johnson J; Noreddin A; Low DE; Karlowsky JA; ; Hoban DJ
    Int J Antimicrob Agents; 2006 Jun; 27(6):468-75. PubMed ID: 16713191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing in vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):5-8; discussion 26-7. PubMed ID: 19667569
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
    Talan DA; Krishnadasan A; Abrahamian FM; Stamm WE; Moran GJ;
    Clin Infect Dis; 2008 Nov; 47(9):1150-8. PubMed ID: 18808361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro resistance of E coli to TMP/SMX and clinical failure.
    Postgrad Med; 2001 Aug; 110(2 Suppl):9-10; discussion 26-7. PubMed ID: 19667570
    [No Abstract]   [Full Text] [Related]  

  • 33. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli.
    Moreno E; Prats G; Sabaté M; Pérez T; Johnson JR; Andreu A
    J Antimicrob Chemother; 2006 Feb; 57(2):204-11. PubMed ID: 16390858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.
    Can F; Azap OK; Seref C; Ispir P; Arslan H; Ergonul O
    Clin Infect Dis; 2015 Feb; 60(4):523-7. PubMed ID: 25378460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of dfr genes associated with integrons and dissemination of dfrA17 among urinary isolates of Escherichia coli in Korea.
    Yu HS; Lee JC; Kang HY; Jeong YS; Lee EY; Choi CH; Tae SH; Lee YC; Seol SY; Cho DT
    J Antimicrob Chemother; 2004 Mar; 53(3):445-50. PubMed ID: 14963060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates.
    Wright SW; Wrenn KD; Haynes ML
    J Gen Intern Med; 1999 Oct; 14(10):606-9. PubMed ID: 10571705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary tract infection in women over the age of 65: is age alone a marker of complication?
    Grover ML; Bracamonte JD; Kanodia AK; Edwards FD; Weaver AL
    J Am Board Fam Med; 2009; 22(3):266-71. PubMed ID: 19429732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.
    Kahlmeter G; Poulsen HO
    Int J Antimicrob Agents; 2012 Jan; 39(1):45-51. PubMed ID: 22055529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of trimethoprim-resistance-conferring dihydrofolate reductase genes in urinary isolates of Escherichia coli in Korea.
    Lee JC; Oh JY; Cho JW; Park JC; Kim JM; Seol SY; Cho DT
    J Antimicrob Chemother; 2001 May; 47(5):599-604. PubMed ID: 11328770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implications. In vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.